Back to mobile site

More on USPH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+4.9% Growth)
- Ratings (6.0 Score)
- Holders
- Dividends (1.9% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

USPH Cash Flow Statement

Click line-items for a historical chart and %
Net income including noncontrolling interests 25.71M
Depreciation and amortization 6.21M
Provision for doubtful accounts 2.96M
Equity-based awards compensation expense 3.75M
(Gain) loss on sale of business and sale or abandonment of assets, net
Deferred income tax 5.69M
Other 0
Increase in patient accounts receivable
Increase in accounts receivable - other
Increase in other assets -4.98M
Decrease in accounts payable and accrued expenses 5.18M
Increase in other liabilities 708K
Net cash provided by operating activities
Purchase of fixed assets -5.62M
Purchase of businesses, net of cash acquired -12.96M
Acquisitions of noncontrolling interests
Net proceeds on sale of fixed assets and business 42K
Net cash used in investing activities
Distributions to noncontrolling interests -8.27M
Cash dividends to shareholders -6.38M
Proceeds from revolving line of credit 128M
Payments on revolving line of credit -136M
Payment of notes payable -592K
Excess tax benefit from stock options exercised
Proceeds from exercise of stock options
Net cash provided by (used in) financing activities
Net increase (decrease) in cash -754K
Cash - beginning of period
Cash - end of period
Income taxes 10.05M
Interest 770K
Purchase of business - seller financing portion 514K
Acquisition of noncontrolling interest - seller financing portion